How to Get on Biotech Podcasts

To get on biotech podcasts, verify the show's current audience and submission route, then propose one scientific or operating decision you can support on the record. State the guest's direct role, the evidence available and the limits around patients, partners and unpublished work. A guest form allows consideration. It does not guarantee a recording, approval or publication.

Biotech pitches carry a higher claim burden than a generic founder story. An interesting premise can touch clinical outcomes, research findings, regulatory work, intellectual property or investor-sensitive information. The pitch has to remain accurate and useful after every restricted detail is removed.

Start with discovery, then return to the official show site

Use the Convokast podcast directory and the shortlist of biotech podcasts for founders and operators to find candidates. Then inspect the publisher's site and newest full episodes. A directory description can lag behind a change in host, format or editorial focus.

Record what the show currently publishes. News analysis, founder interviews, scientific conversations, manufacturing discussions and pharma-services programs ask for different guests. Note the technical level, the professional roles represented and whether the host presses speakers on evidence or concentrates on personal experience.

Look for a guest-specific route. The Molecule to Market guest page describes an introductory conversation and says its interviews cover a guest's background, sector experience, operating lessons, leadership and relevant trends in the pharma and biopharma outsourcing ecosystem. The Bioprocessing Unfiltered application invites people to be considered for a future episode and says the team follows up when an applicant fits its production schedule. The Biotech2050 participation page says the show is seeking guests and thought leaders and accepts self-submissions or nominations.

Define the audience more narrowly than biotech

A genetics researcher, process-development scientist, clinical operator, company founder, biotech investor and contract manufacturing executive can all listen to biotech podcasts for different reasons. A pitch aimed at "life-sciences leaders" tells the producer almost nothing about who should care.

Read recent episode descriptions for recurring decisions and vocabulary. A bioprocessing show may expect discussion of upstream work, downstream work, analytics, quality or manufacturing. A company-building show may focus on financing, team design, regulatory planning or portfolio choices. An outsourcing program may care about partner selection, technical transfer and sponsor responsibilities.

Use an audience-overlap check to compare that listener with the people the guest can help. Describe the audience through a job and decision, such as an emerging-biopharma founder planning an external development partnership or a process leader evaluating a manufacturing change.

A well-known title does not create fit. A scientist with direct work on the subject may be stronger than an executive offering broad market commentary. The producer needs a speaker who can answer follow-up questions without drifting beyond their evidence.

Guest access and scientific fit require different evidence

A published application answers where to submit. It does not answer whether the topic, claim or guest belongs on the show.

The guide to checking whether a podcast takes guests explains how to rank these signals. Check again immediately before outreach. A form can remain indexed after the editorial process changes.

Do not convert a general publisher contact page into an acceptance claim. Life-sciences publishers may operate conferences, reports, advertising, webinars and podcasts under one brand. Use the route that explicitly belongs to the show, and keep sponsorship requests separate from editorial ideas.

Pitch one decision rather than an entire company journey

A producer can build an interview around a bounded decision, tension or research question. A complete company story often spans too many stages and produces a shallow tour. Choose the point where the guest's judgment can help the show's audience.

Possible angle shapes include:

• how a team decided what work a development partner would own
• what changed after a process failed to transfer as expected
• how a founder sequenced scientific hiring under a capital constraint
• how a research team separated an early signal from a conclusion
• what an operator learned while preparing evidence for a regulated step

These are structures, not claims about real programs. The guest must replace them with a subject they can discuss and support. Define the modality, development stage, operating setting and affected role when those conditions change the lesson.

Avoid future-of-biotech pitches built from predictions alone. A defensible thesis links the forecast to evidence, names the conditions under which it may hold and explains what would change the speaker's view.

A founder can mention the company and product when they are relevant to the decision. The conversation should still help listeners who never become customers. If removing the product name removes the lesson, the idea belongs in a commercial route.

Run a claim, confidentiality and disclosure review

Sort every proposed talking point into direct knowledge, public evidence, interpretation or restricted material.

Direct knowledge includes work the guest personally conducted, reviewed or decided. Public evidence may include peer-reviewed research, trial registries, regulator documents, company filings or other records a producer can inspect. Interpretation covers what the guest concludes from that material and should preserve uncertainty. Restricted material can include patient information, unpublished findings, partner data, confidential protocols, intellectual property, internal forecasts and facts subject to an agreement.

Clinical and scientific language needs particular care. Do not turn an early result into an established outcome, imply regulatory approval where none exists or extend a finding beyond the population and conditions studied. A podcast is not a substitute for the underlying record. Link the producer to the record and explain the guest's relationship to it.

Disclose employment, equity, advisory work, investment, vendor relationships and sponsorship that could shape the conversation. Producers can decide how to handle a declared interest. Discovering it after the recording creates an avoidable editorial problem.

Get internal clearance before submitting when the topic involves an employer, trial, patient, partner or nonpublic program. The pitch should not be the first place a legal, medical, regulatory or communications owner learns that the material may become public.

Write a concise pitch that can be checked

Open with the listener problem and proposed conversation. Follow with the speaker's direct role and the evidence available for review. State the claim boundary in plain language. A recent-episode reference belongs only when it shows real continuity or a distinct perspective.

A producer should be able to identify:

• the precise life-sciences audience
• the decision or research question
• why this speaker knows it directly
• which public records support the conversation
• which details cannot be discussed
• which commercial or professional interests require disclosure

Add a short biography and links that establish subject expertise and communication quality. Do not bury the topic beneath awards, employer descriptions or a full career history.

Follow the route's instructions. Bioprocessing Unfiltered asks what message would interest its community. Biotech2050 accepts a proposed guest or nomination. Molecule to Market describes an introductory call before recording. Respond to the process on the page rather than forcing every show into the same email template.

The list of biotech podcasts with published guest routes can reduce initial research. Verify the current page before using any route because editorial policies and production schedules change.

Prepare the public version of the story before acceptance

Outline the conversation and test every example against its permission and evidence status. Prepare a short explanation of what the guest cannot discuss, followed by an adjacent lesson that is still useful. A boundary should protect the material without ending the interview.

Listen to the host's follow-ups. Some hosts want experimental detail. Others focus on company decisions, leadership or market structure. Practise answering at the show's level while identifying assumptions and uncertainty. Prepare the source links a producer may need for show notes or fact checking.

Confirm whether the episode is editorial, sponsored or tied to another commercial arrangement. Ask about recording format, review expectations and disclosure language. Approval rights vary by publisher, so do not assume a guest can revise the final episode unless the show explicitly offers that process.

When the audience, route, evidence and approvals are ready, turn the research into a short submission with the podcast pitch generator.